mondo_id	label	definition	obsolete	obsoletion_candidate
MONDO:0100551	SPATA5L1-related complex neurodevelopmental disorder with motor features and hearing loss	A neurodevelopmental disorder related to biallelic variants in SPATA5L1 and characterized by a spectrum of intellectual disability, hearing loss, and motor features including spasticity, dystonia, and/or hypotonia. Other phenotypic features commonly reported with the neurodevelopmental presentation include spasticity, focal or generalized epilepsy, and microcephaly.		
MONDO:0100552	ATTRV30M amyloidosis	A rare hereditary ATTR amyloidosis (hATTR) characterized by a progressive, length-dependent sensorimotor axonal polyneuropathy and/or autonomic neuropathy in adulthood. Renal, ocular and cardiac involvement also frequently occurs. Two different phenotypes are associated with this mutation, namely early-onset V30M and late-onset V30M, that differ in terms of age on onset (<50 years or >50 years, respectively), presenting features, histopathological characteristics, rate of disease progression and response to therapy.		
MONDO:0100553	OPTN-related open angle glaucoma	Any open angle glaucoma in which the cause of the disease is a mutation in the OPTN gene.		
MONDO:0100554	hereditary narcolepsy	An instance of narcolepsy that is caused by an inherited genomic modification in an individual.		
MONDO:0100555	IgA nephropathy, susceptibility to	An inherited susceptibility or predisposition to developing IgA glomerulonephritis.		
MONDO:0700245	epidermolytic hyperkeratosis 2B, autosomal recessive			
MONDO:0700248	epidermolytic hyperkeratosis 2A, autosomal dominant			
MONDO:0700249	epidermolytic hyperkeratosis 1			
MONDO:0700250	mitochondrial complex IV deficiency, nuclear type 1			
MONDO:0700251	orofacial cleft 7			
MONDO:0700252	parneoplastic endocrine syndrome	Paraneoplastic syndrome that involves the endocrine system.		
MONDO:0700253	paraneoplastic hematological syndrome	Paraneoplastic syndrome that involves the hematopoietic system.		
MONDO:0700254	paraneoplastic gastrointestinal syndrome	Paraneoplastic syndrome that involves the digestive system.		
MONDO:0700255	paraneoplastic renal syndrome	Paraneoplastic syndrome that involves the renal system.		
MONDO:0700256	TREX1-related type 1 interferonopathy	Any type 1 interferonopathies in which the cause of the disease is a variation in the TREX1 gene. Individuals with variants in TREX1 can present with a variety of phenotypes, including Aicardi-Goutieres syndrome, chilblain lupus, or retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations.		
MONDO:0700257	RNASEH2B-related type 1 interferonopathy	Any type 1 interferonopathies in which the cause of the disease is a variation in the RNASEH2B gene. Individuals with variants in RNASEH2B can present with a variety of phenotypes, including Aicardi-Goutieres syndrome.		
MONDO:0700258	RNASEH2C-related type 1 interferonopathy	Any type 1 interferonopathies in which the cause of the disease is a variation in the RNASEH2C gene. Individuals with variants in RNASEH2C can present with a variety of phenotypes, including Aicardi-Goutieres syndrome.		
MONDO:0700259	RNASEH2A-related type 1 interferonopathy	Any type 1 interferonopathies in which the cause of the disease is a variation in the RNASEH2A gene. Individuals with variants in RNASEH2A can present with a variety of phenotypes, including Aicardi-Goutieres syndrome.		
MONDO:0700260	SAMHD1-related type 1 interferonopathy	Any type 1 interferonopathies in which the cause of the disease is a variation in the SAMHD1 gene. Individuals with variants in SAMHD1 can present with a variety of phenotypes, including Aicardi-Goutieres syndrome and chilblain lupus.		
MONDO:0700261	ADAR-related type 1 interferonopathy	Any type 1 interferonopathies in which the cause of the disease is a variation in the ADAR gene. Individuals with variants in ADAR can present with a variety of phenotypes, including Aicardi-Goutieres syndrome and dyschromatosis symmetrica hereditaria.		
MONDO:0700262	IFIH1-related type 1 interferonopathy	Any type 1 interferonopathies in which the cause of the disease is a variation in the IFIH1 gene. Individuals with variants in IFIH1 can present with a variety of phenotypes, including Aicardi-Goutieres syndrome and singleton-Merten syndrome.		
MONDO:0700263	RNU7-1-related type 1 interferonopathy	Any type 1 interferonopathies in which the cause of the disease is a variation in the RNU7-1 gene. Individuals with variants in RNUF7-1 can present with a variety of phenotypes, including Aicardi-Goutieres syndrome.		
MONDO:0700264	type 1 interferonopathy	Conditions in which increased type 1 interferon signaling leads to autoimmune and neurological disorders. These disorders are caused by variants in genes involved in nucleic acid metabolism, sensing, and the innate immune response.		
MONDO:0700265	paraneoplastic rheumatic syndrome	Paraneoplastic syndrome that involves the joints, bones, muscles, and/or connective tissue.		
MONDO:0700266	paraneoplastic cutaneous syndrome	Paraneoplastic syndrome that involves the integumental system.		
MONDO:0956962	benign teratoma	A germ cell benign neoplasm that derives from mature tissue elements or a limited amount of immature tissue elements.		
MONDO:0956964	medulloblastoma SHH activated and TP53 mutant	A medulloblastoma SHH activated that is characterized as a molecular subtype by activation of the sonic hedgehog (SHH) pathway and the presence of TP53 mutations.		
MONDO:0956965	medulloblastoma SHH activated and TP53 wild-type	A medulloblastoma SHH activated that is characterized as a molecular subtype by activation of the sonic hedgehog (SHH) pathway and the absence of TP53 mutations.		
MONDO:0956966	medulloblastoma non-WNT/non-SHH group 3	A medulloblastoma non-WNT/non-SHH that is characterized as a molecular subtype by absent TP53 mutations and MYC amplifications that may be present.		
MONDO:0956967	medulloblastoma non-WNT/non-SHH group 4	A medulloblastoma non-WNT/non-SHH that is characterized as a molecular subtype by the absence of MYC amplifications and TP53 mutations, while chromosome 17 abnormalities may be present.		
MONDO:0956969	chronic inducible urticaria	A chronic urticaria that is characterized by a history of a consistent stimulus that initiates lesions, which are typically short-lived and fleeting, lasting a few minutes up to 2 hours.		
MONDO:0956971	intermittent asthma	A chronic asthma that is characterized by severity with symptoms two or fewer days per week, nighttime awakenings two or fewer times per month, use of short-acting beta agonist for symptom control two or fewer days per week and no interference with normal activity.		
MONDO:0956975	T2-high asthma	A chronic asthma that is characterized by the pathophysiology phenotype combination (endotype) of early-onset allergic asthma, late-onset eosinophilic asthma, and aspirin-exacerbated respiratory disease.		
MONDO:0956976	T2-low asthma	A chronic asthma that is characterized by the pathophysiology phenotype combination (endotype) of non-atopic, smoking, obesity related, and elderly and that is characterized by neutrophilic (sputum neutrophils > 40â€“60%) or paucigranulocytic (i.e., normal sputum levels of both eosinophils and neutrophils) inflammation and a lack of response to corticosteroid therapy.		
MONDO:0956977	near-fatal asthma	An acute asthma that is characterized by a respiratory arrest or arterial carbon dioxide tension greater than 50 mmHg, with or without altered consciousness, requiring mechanical ventilation.		
MONDO:0956979	nocturnal asthma	A chronic asthma that is characterized by significant decline in pulmonary function and increase of airway inflammation at night. During sleep, recumbent posture causes a reduction in the lung volumes, respiratory muscle tone, and lung compliance. The overnight physiological abnormalities include: increased airway inflammation and decreased steroid responsiveness, increased pulmonary capillary blood volume, functional differences in blood/air volume ratios and mechanical coupling of the parenchyma to the airways.		
MONDO:0956980	vascular parkinsonism	A Parkinsonism that is characterized by postural instability, a broad-based gait with the absence of tremors of vascular origin.		
MONDO:0956981	astrocytoma, IDH-mutant, grade 4	An IDH-mutant anaplastic astrocytoma that is characterized by the presence of necrosis and/or microvascular proliferation or homozygous deletion of CDKN2A and/or CDKN2B genes. The term glioblastoma no longer applies to central nervous system WHO grade 4 IDH-mutant astrocytomas.		
MONDO:0956983	pleomorphic xanthoastrocytoma BRAF mutant	An anaplastic pleomorphic xanthoastrocytoma that has material basis in BRAF mutations.		
MONDO:0956984	YAP1-MAMLD1 fusion-positive supratentorial ependymoma	A supratentorial ependymoma that has material basis in YAP1-MAMLD1 fusion.		
MONDO:0956985	lipofibromatosis-like neural tumor	A connective tissue cancer that has material basis in LMNA-NTRK1 gene fusion.		
MONDO:0956986	solitary fibrous tumor/hemangiopericytoma	A connective tissue cancer that is characterized as the combination of solitary fibrous tumors and hemangiopericytomas.		
MONDO:0956987	EZB-MYC+ diffuse large B-cell lymphoma	An EZB diffuse large B-cell lymphoma that expresses the double hit gene expression signature (DHITsig+) according to gene expression profiling. In addition to the features characteristic of EZB, these cases commonly, but do not always, harbour MYC translocations and DDX3X mutations.		
MONDO:0956988	EZB-MYC- diffuse large B-cell lymphoma	An EZB diffuse large B-cell lymphoma that does not express the double hit gene expression signature (DHITsig-) according to gene expression profiling. These cases tend to have few MYC translocations or DDX3X mutations.		
MONDO:0956989	CIC-rearranged sarcoma	An EWSERI-negative small round cell tumor that is characterized by a recurrent translocation involving the CIC gene on chromosome 19 and either DUX4 gene on chromosome 4 or DUX4L gene on chromosome 10. The translocation results in either CIC-DUX4, t(4;19)(q35;q13) or CIC-DUX4L, t(10;19)(q26;q13) fusions.		
MONDO:0956990	supratentorial ependymoma, ZFTA fusionâ€“positive	A suptratentorial ependymoma that is characterized by the presence of a fusion gene involving ZFTA gene.		
MONDO:0956991	supratentorial ependymoma, YAP1 fusionâ€“positive	A supratentorial ependymoma that is characterized by the presence of a fusion gene involving YAP1 gene.		
MONDO:0956992	posterior fossa group A ependymoma	A posterior fossa ependymoma that arises in the posterior fossa with characteristic DNA methylation patterns, including CpG island hypermethylation, global DNA hypomethylation, reduction of nuclear H3 p.K28me3 (K27me3) expression, and EZHIP overexpression.		
MONDO:0956993	posterior fossa group B ependymoma	A posterior fossa ependymoma that arises in the posterior fossa with characteristic DNA methylation patterns including retention of nuclear H3 p.K28me3 (K27me3) expression, absence of CpG island hypermethylation, absence of global DNA hypomethylation, and absence of EZHIP overexpression.		
MONDO:0956994	astrocytoma, IDH-mutant, grade 2	An IDH-mutant anaplastic astrocytoma that is characterized by the presence of well-differentiated fibrillary glial cells diffusely infiltrating the central nervous system.		
MONDO:0956995	astrocytoma, IDH-mutant, grade 3	An IDH-mutant anaplastic astrocytoma that is characterized by the presence of increased mitotic activity and anaplastic features.		
MONDO:0956996	oligodendroglioma, IDH-mutant and 1p/19q-codeleted grade 2	An IDH-mutant, and 1p/19q-codeleted oligodendroglioma that is characterized as a well differentiated tumor lacking anaplastic features (brisk mitotic activity, microvascular proliferation, necrosis).		
MONDO:0956997	oligodendroglioma, IDH-mutant and 1p/19q-codeleted, grade 3	An IDH-mutant, and 1p/19q-codeleted oligodendroglioma that is characterized as grade 3 tumors associated with a more rapid growth. Grade 3 tumors appear to have abnormalities on chromosomes 9 or 10, along with unusual amounts of growth factors and proteins, which are thought to contribute to the more rapid growth of these gliomas.		
MONDO:0957196	diffuse midline glioma, H3 K27M-mutant	A histone mutated tumor that is characterized by the presence of histone H3 K27M mutation located throughout the midline structures of the central nervous system.		
MONDO:0957197	diffuse glioma, H3 G34 mutant	A histone mutated tumor that has material basis in mutations in codon 34 of the H3 histone family 3A protein.		
MONDO:0957519	diffuse gastric cancer	A stomach cancer that is characterized by development of diffuse (signet ring cell) gastric cancer underneath the stomach lining.		
MONDO:0957524	COX deficiency, benign infantile mitochondrial myopathy	A cytochrome-c oxidase deficiency disease characterized by localization to tissues of the skeletal muscles.		
MONDO:0957896	metabolic dysfunction and alcohol associated liver disease	A steatotic liver disease characterized by at least one of the five cardiometabolic risk factors for MASLD and alcohol consumption of 140-350g/week (females) or 210-420g/week (males). This disease is distinguished from MASLD by increased alcohol consumption and from ALD by the evidence of one or more of the MASLD cardiometabolic risk factors.		
MONDO:0957912	organophosphate-induced delayed polyneuropathy	An inflammatory and toxic neuropathy that is characaterized by a collection of neuropsychological symptoms associated with repeated organophosphate pesticide exposure as well as nerve agent exposure. Symptoms can appear weeks after exposure and include muscle weakness, anxiety, depression, psychosis as well as cognitive and memory deficits.		
MONDO:0958071	Hao-Fountain syndrome due to USP7 mutation			
MONDO:0958075	intramedullary non-dysraphic spinal cord lipoma	A very rare non-dysraphic spinal cord lipoma characterized by being located within the spinal cord. There is no defect in the overlying dura.		
MONDO:0958076	myeloschisis	A rare form of spina bifida/open neural tube defect (NTD) chacterized by absence of a cystic component, dysplastic meninges and neural placode exposed through a defect in the posterior vertebral arches (spina bifida) that are contiguous with surrounding skin. The placode is at or below the skin plane and is typically associated with a Chiari II malformation. It is usually isolated or rarely associated with split cord malformation.		
MONDO:0958077	collagen 6-related congenital muscular dystrophy			
MONDO:0958085	digenic hemochromatosis	A rare subtype of hemochromatosis characterized by the combination of pathogenic variants in two genes involved in iron metabolism (usually a combination of HFE and non-HFE mutations), where the classical HFE-related hemochromatosis is not enough to fully explain the clinical picture of the patient.		
MONDO:0958093	non-syndromic supernumerary kidneys			
MONDO:0958095	Nodal T-follicular helper cell lymphoma, follicular type			
MONDO:0958096	monomorphic epitheliotropic intestinal T-cell lymphoma			
MONDO:0958097	primary superior vena cava aneurysm			
MONDO:0958098	primary inferior vena cava aneurysm			
MONDO:0958099	idiopathic subglottic stenosis			
MONDO:0958101	lymphocytic mastitis			
MONDO:0958104	digenic Alport syndrome			
MONDO:0958122	idiopathic small fibers neuropathy			
MONDO:0958123	isolated pulmonary artery sling			
MONDO:0958128	non-transplant-related bronchiolitis obliterans			
MONDO:0958129	COQ7-related distal hereditary motor neuropathy			
MONDO:0958130	Greig cephalopolysyndactyly-contiguous gene syndrome			
MONDO:0958137	early-onset autoimmune disorder due to DOCK11 partial deficiency			
MONDO:0958138	early-onset immune dysregulation due to DOCK11 complete deficiency			
MONDO:0958150	Borrelia miyamotoi disease			
MONDO:0958151	cepacia syndrome			
MONDO:0958159	sarcoma with BCOR genetic alterations	A small cell sarcoma that is characterized by the presence of small round or elongated malignant cells with a small amount of cytoplasm and the presence of BCOR genetic alterations.		
MONDO:0958160	round cell sarcoma with EWSR1-non-ETS fusion	A small cell sarcoma that is characterized by the presence of EWSR1 or FUS fusions involving partners unrelated to the ETS gene family.		
MONDO:0958161	B acute lymphoblastic leukemia with PAX5 P80R mutation	A B-lymphoblastic leukemia/lymphoma that is associated with PAX5 P80R mutation.		
MONDO:0958162	B acute lymphoblastic leukemia with DUX4 rearrangement	A B lymphoblastic leukemia/lymphoma that is associated with DUX4 gene rearrangement.		
MONDO:0958164	poorly differentiated chordoma	A chordoma that is characterized by loss of SMARCB1 expression and that is composed of sheets or nests of malignant epithelioid cells with abundant eosinophilic cytoplasm.		
MONDO:0958165	anaplastic sarcoma of the kidney	A kidney sarcoma that is characterized by a proliferation of anaplastic spindle cells with bizarre, pleomorphic nuclei and atypical mitotic figures.		
MONDO:0958224	encephalopathy, porphyria-related			
MONDO:0958226	leukoencephalopathy, porphyria-related			
MONDO:0958227	polydactyly-macrocephaly syndrome			
MONDO:0958228	hearing loss, autosomal recessive 122			
MONDO:0958229	bleeding disorder, vascular-type			
MONDO:0958230	orofaciodigital syndrome 20			
MONDO:0958231	neurodevelopmental disorder with motor abnormalities, seizures, and facial dysmorphism			
MONDO:0958232	hearing loss, autosomal dominant 90			
MONDO:0958233	Bethlem myopathy 1B			
MONDO:0958234	Bethlem myopathy 1C			
MONDO:0958235	Ullrich congenital muscular dystrophy 1B			
MONDO:0958236	Ullrich congenital muscular dystrophy 1C			
MONDO:0958237	isolated hyperferritinemia			
MONDO:0958238	hyperemesis gravidarum, susceptibility to			
MONDO:0958239	microphthalmia/coloboma 11			
MONDO:0958240	neurodevelopmental disorder with hyperkinetic movements, seizures, and structural brain abnormalities			
MONDO:0958241	cardiomyopathy, familial hypertrophic, 30, atrial			
MONDO:0958242	spermatogenic failure 90			
MONDO:0958256	pyoderma gangrenosum-acne-hidradenitis suppurativa-ankylosing spondylitis syndrome			
MONDO:0958257	psoriatic arthritis-pyoderma gangrenosum-acne-hidradenitis suppurativa syndrome			
MONDO:0958258	Cushing syndrome due to cortisol-producing adrenocortical adenoma			
MONDO:0958259	dysraphism with stalk	A rare group of closed spinal dysraphisms characterized by the presence of a stalk connecting the skin to the underlying spinal cord. The stalk contains variable combinations of non-functional neural tissue, fibrous mesenchymal tissue, and dermal/epidermal elements.		
MONDO:0958260	dysraphic spinal cord lipoma	A rare group of spinal cord lipoma characterized by the presence of extramedullary lipomatous mass located at any point along the spinal cord with or without a dural defect.		
MONDO:0958262	isolated primary pigmented nodular adrenocortical disease			
MONDO:0958263	isolated micronodular adrenocortical disease			
MONDO:0958264	infectious scleritis			
MONDO:0958265	idiopathic scleritis			
MONDO:0958266	immune-mediated scleritis			
MONDO:0958267	non-syndromic bridging bronchus			
MONDO:0958268	non-syndromic congenital bronchial atresia			
MONDO:0958269	isolated left bronchial isomerism			
MONDO:0958270	central precocious puberty in male			
MONDO:0958273	cleft palate-congenital heart defect-intellectual disability syndrome due to MEIS2 mutation			
MONDO:0958274	benign atrophic papulosis			
MONDO:0958275	segmental spinal dysgenesis			
MONDO:0958277	hearing loss, autosomal recessive 123			
MONDO:0958278	neurodevelopmental disorder with hypotonia and characteristic brain abnormalities			
MONDO:0958279	megalencephaly-polydactyly syndrome			
